| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,268,249 |
|
|
|
Indirect Value
|
$149,961,660 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$151,229,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
265,500 |
796,333 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
265,500 |
1,366,348 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-24 |
4 |
A |
$0.00 |
$0 |
I/I |
265,500 |
1,631,848 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
265,500 |
530,833 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-25 |
4 |
A |
$0.00 |
$0 |
I/I |
265,500 |
1,897,348 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
265,500 |
265,333 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-26 |
4 |
A |
$0.00 |
$0 |
I/I |
265,333 |
2,162,681 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
265,333 |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-11-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
2,158,681 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
41,458 |
68,124 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
174,092 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-08-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
2,154,681 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
129,108 |
248,658 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-11-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
2,149,681 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
67,240 |
232,656 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2016-08-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,800 |
2,316,849 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2016-11-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
2,306,849 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
11,558 |
2,318,407 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,794 |
31,081 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,558 |
12,453 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
2,308,407 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
23,273 |
36,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,393 |
19,602 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
9,393 |
2,317,800 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2020-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
198,124 |
198,124 |
0 |
- |
|
193 Records found
|
|
Page 2 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
